CJC-1295 + Ipamorelin is a USA-manufactured dual-peptide GH axis research blend combining CJC-1295 No DAC (ModGRF 1-29) a synthetic GHRH analogue that activates the GHRH receptor on anterior pituitary somatotrophs via Gs-cAMP signaling and Ipamorelin, a selective GH secretagogue that activates the ghrelin receptor (GHS-R1a) via the distinct Gq/11 intracellular pathway, providing simultaneous dual-receptor GH axis stimulation in a single research preparation
Created to combat obesity and diabetes, GLP-1 agonists are now being assessed in dozens of disorders
In many cases, yes, especially if you have gut absorption issues (e.g., IBS, low stomach acid, post-surgery) or if youre already depleted
Providers often discuss nutrition, activity, and lifestyle changes to help maintain results long term
Further studies are warranted to determine whether this is also true for glutamate and cysteine (other two precursors of GSH)
Among these, Parkinson's disease (PD) stands out as the second most prevalent neurodegenerative disorder [1]